245 related articles for article (PubMed ID: 25103328)
21. [Female patient with Muir-Torre syndrome].
Negraszus N; Jöhrens K; Bertelmann E
Ophthalmologe; 2010 Nov; 107(11):1059-62. PubMed ID: 20393721
[TBL] [Abstract][Full Text] [Related]
22. PRAME immunostain expression in sebaceous lesions, cutaneous carcinomas and adnexal structures.
Ng JKM; Choi PCL; Chow C; Li JJX; Chan AWS; Cheung CMT; Ip ECC; Ng HK; To KF
Pathology; 2022 Oct; 54(6):721-728. PubMed ID: 35644638
[TBL] [Abstract][Full Text] [Related]
23. Nuclear factor XIIIa staining (clone AC-1A1 mouse monoclonal) is a highly sensitive marker of sebaceous differentiation in normal and neoplastic sebocytes.
Clark LN; Elwood HR; Uhlenhake EE; Smoller BR; Shalin SC; Gardner JM
J Cutan Pathol; 2016 Aug; 43(8):657-62. PubMed ID: 27153463
[TBL] [Abstract][Full Text] [Related]
24. [Clinical presentation of cutaneous adnexal tumors].
Zelger B; Kazakov DV; Zelger BG
Pathologe; 2014 Sep; 35(5):487-96. PubMed ID: 25154603
[TBL] [Abstract][Full Text] [Related]
25. Sebaceous neoplasms and the Muir-Torre syndrome.
Elston DM
J Am Acad Dermatol; 2023 Dec; 89(6):1123. PubMed ID: 37172735
[No Abstract] [Full Text] [Related]
26. Molecular Genetics of Sebaceous Neoplasia.
North JP
Surg Pathol Clin; 2021 Jun; 14(2):273-284. PubMed ID: 34023105
[TBL] [Abstract][Full Text] [Related]
27. [Case report: Muir-Torre syndrome diagnosed from a sebaceoma mimicking an ulcerated breast cancer].
Demolin G; Romain M; Münschke A; Vandingenen T; Blaude MA; Van Craynest MP
J Gynecol Obstet Biol Reprod (Paris); 2016 Sep; 45(7):767-74. PubMed ID: 26321614
[TBL] [Abstract][Full Text] [Related]
28. Muir-Torre syndrome: case report and review of the literature.
Ang JM; Alai NN; Ritter KR; Machtinger LA
Cutis; 2011 Mar; 87(3):125-8. PubMed ID: 21488569
[TBL] [Abstract][Full Text] [Related]
29. [Malignant adnexal carcinomas of the skin].
Klit A; Hærskjold A; Lei U; Skødt V; Drejøe JB
Ugeskr Laeger; 2016 Jun; 178(26):. PubMed ID: 27402128
[TBL] [Abstract][Full Text] [Related]
30. [Sebaceous hyperplasia of the lower eyelid].
Spraul CW; Jakobczyk-Zmija MJ; Lang GK
Klin Monbl Augenheilkd; 1999 Nov; 215(5):319-20. PubMed ID: 10609249
[TBL] [Abstract][Full Text] [Related]
31. Universal immunohistochemical screening of sebaceous neoplasms for Muir-Torre syndrome: Putting the cart before the horse?
Kim RH; Nagler AR; Meehan SA
J Am Acad Dermatol; 2016 Nov; 75(5):1078-1079. PubMed ID: 27745640
[No Abstract] [Full Text] [Related]
32. Sebaceous lesions and their associated syndromes: part I.
Eisen DB; Michael DJ
J Am Acad Dermatol; 2009 Oct; 61(4):549-60; quiz 561-2. PubMed ID: 19751879
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathological study of 47 cases of sebaceoma.
Bourlond F; Velter C; Cribier B
Ann Dermatol Venereol; 2016 Dec; 143(12):814-824. PubMed ID: 27836252
[TBL] [Abstract][Full Text] [Related]
34. Molecular pathology of skin adnexal tumours.
Plotzke JM; Adams DJ; Harms PW
Histopathology; 2022 Jan; 80(1):166-183. PubMed ID: 34197659
[TBL] [Abstract][Full Text] [Related]
35. Update on the pathology, genetics and somatic landscape of sebaceous tumours.
Ferreira I; Wiedemeyer K; Demetter P; Adams DJ; Arends MJ; Brenn T
Histopathology; 2020 Apr; 76(5):640-649. PubMed ID: 31821583
[TBL] [Abstract][Full Text] [Related]
36. Muir-Torre Syndrome Masquerading as Chalazion.
Makrygiannis G; Vahdani K; Giasin O
Ophthalmic Plast Reconstr Surg; 2015; 31(5):422-3. PubMed ID: 26352527
[No Abstract] [Full Text] [Related]
37. Characteristic Ber-EP4 and EMA expression in sebaceoma is immunohistochemically distinct from basal cell carcinoma.
Fan YS; Carr RA; Sanders DS; Smith AP; Lazar AJ; Calonje E
Histopathology; 2007 Jul; 51(1):80-6. PubMed ID: 17593083
[TBL] [Abstract][Full Text] [Related]
38. Muir-Torre syndrome: sebaceous carcinoma concurrent with colon cancer in a kidney transplant recipient; a case report.
Tomonari M; Shimada M; Nakada Y; Yamamoto I; Itoh M; Koike Y; Kobayashi A; Miki J; Yamada H; Kimura T; Saito S; Sugano K; Sekine S; Yamamoto H; Asahina A; Yokoo T
BMC Nephrol; 2019 Oct; 20(1):394. PubMed ID: 31664942
[TBL] [Abstract][Full Text] [Related]
39. A case of Muir-Torre syndrome with a keratoacanthoma and sebaceous neoplasms: Clinicopathological features and a speculation on the pathogenesis of cutaneous tumor type.
Takayama E; Yoshioka A; Takai T; Goto K
J Dermatol; 2021 May; 48(5):690-694. PubMed ID: 33523490
[TBL] [Abstract][Full Text] [Related]
40. MSH6 mutation in a family affected by Muir-Torre syndrome.
Kacerovska D; Cerna K; Martinek P; Grossmann P; Michal M; Ricar J; Kazakov DV
Am J Dermatopathol; 2012 Aug; 34(6):648-52. PubMed ID: 22814321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
